Literature DB >> 7440713

Radioimmunoassay studies of human apolipoprotein E.

C B Blum, L Aron, R Sciacca.   

Abstract

This report describes the development and first applications of a sensitive and specific double antibody radioimmunoassay for human apoplipoprotein E (apoE). ApoE was purified from the very low density lipoproteins of hypertriglyceridemic patients by heparin-agarose affinity chromatography, DEAE-cellulose chromatography, and preparative polyacrylamide gel electrophoresis. The purified apoprotein had an amino acid composition characteristic of apoE and resulted in the production of monospecific antisera when injected into rabbits. The radioimmunoassay, which was carried out in the presence of 5 mM sodium decyl sulfate, had a working range of 0.8-12 ng. The withinassay coefficient of variation was 9% and the coefficient of variation for systematic between-assay variability was 3%. Prior delipidation of samples with organic solvents did not alter their immunoreactivity. In 26 normal volunteers, the mean plasma apoE concentration was 36 +/- 13 microgram/ml. Hyperlipidemic patients (n = 68) had higher mean apoE levels. A single patient with type III hyperlipoproteinemia had a plasma apoE level of 664 microgram/ml. The plasma apoE level was independently related to plasma cholesterol and triglyceride levels in a population of 108 normal and nonchylomicronemic hyperlipidemic patients. The multiple correlation coefficient for this relationship was 0.73. Thus, variation in plasma cholesterol and triglyceride concentrations described 53% of the variation in apoE concentrations in this population. The lipoprotein distribution of apoE was investigated by agarose column chromatography and ultracentrifugation of plasma. Agarose column chromatography demonstrated that all or nearly all plasma apoE is associated with lipoproteins. In plasma from normal volunteers and hypercholesterolemic patients, apoE was found in two discrete lipoprotein classes: very low density lipoproteins and a set of lipoprotein particles with size and density characteristics similar to HDL2. In hypertriglyceridemic patients, nearly all apoE was associated with the triglyceride-rich lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440713      PMCID: PMC371608          DOI: 10.1172/JCI109975

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Study of the ferric chloride method for determination of total cholesterol and cholesterol esters.

Authors:  N CHIAMORI; R J HENRY
Journal:  Am J Clin Pathol       Date:  1959-04       Impact factor: 2.493

3.  A new apoprotein of human plasma very low density lipoproteins.

Authors:  F A Shelburne; S H Quarfordt
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

4.  Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components.

Authors:  V G Shore; B Shore
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia.

Authors:  R W Mahley; K H Weisgraber; T Innerarity
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

7.  A weighted least-squares technique for the analysis of kinetic data and its application to the study of renal xenon washout in dogs and man.

Authors:  R B Dell; R Sciacca; K Lieberman; D B Case; P J Cannon
Journal:  Circ Res       Date:  1973-01       Impact factor: 17.367

8.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

9.  Coupling of glycosaminoglycans to agarose beads (sepharose 4B).

Authors:  P H Iverius
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

10.  Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.

Authors:  R J Havel; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

View more
  20 in total

Review 1.  Apolipoprotein E.

Authors:  V I Zannis; J L Breslow
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

2.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.

Authors:  M L Blue; D L Williams; S Zucker; S A Khan; C B Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

Authors:  A Rubinstein; J C Gibson; J R Paterniti; G Kakis; A Little; H N Ginsberg; W V Brown
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Association of plasma lipoproteins with postheparin lipase activities.

Authors:  I J Goldberg; J J Kandel; C B Blum; H N Ginsberg
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.

Authors:  G Ghiselli; E J Schaefer; L A Zech; R E Gregg; H B Brewer
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats.

Authors:  J D Sparks; R Zolfaghari; C E Sparks; H C Smith; E A Fisher
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

10.  Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

Authors:  W März; M W Baumstark; H Scharnagl; V Ruzicka; S Buxbaum; J Herwig; T Pohl; A Russ; L Schaaf; A Berg
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.